About 1.2% of U.S. adult men and 0.3% to 0.7% of U.S. adult women are considered to have clinically significant levels of psychopathic traits. Those numbers rise exponentially in prison, where 15% to 25% of inmates show these characteristics (Burton, B., & Saleh, F. M.,
Psychiatric Times
opens in new window, Vol. 37, No. 10, 2020). That said, psychopathy spans socioeconomic status, race, gender, and culture, and those who score high on psychopathy scales range from high-functioning executives to prison inmates to people whose psychopathic symptoms may reflect difficult life circumstances more than anything else.
“In any culture you visit, you can describe the key personality features of someone with psychopathy and ask, ‘Are there people like this in your society?’” Marsh said. “And they will say, ‘Oh, yeah.’ But the way that these traits are interpreted by people and the way that they manifest in behavior—that can be extremely variable.”
For these and other reasons, the mental health community has not had an easy time homing in on a uniform definition of psychopathy. For decades, its symptoms were examined in two very different populations: people in criminal or forensic settings and people in inpatient or community mental health settings. These groups had somewhat different characteristics, which led to different ways of conceptualizing and assessing psychopathy, said Florida State University psychologist Chris Patrick, PhD, who studies and has written extensively on the condition.
To add to the complexity, psychopathy is not a diagnostic category in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V)—one reason the area tends to be both underfunded and undertreated, Marsh added. In part, that is due to earlier disagreements in the field: Some of those studying the disorder worried that a psychopathy diagnosis would stigmatize people too much, while others were concerned that clinicians would have difficulty in accurately assessing traits like callousness or cruel or indifferent disregard of others. So, although psychopathy was included in the first two editions of the DSM, it was replaced in the third edition by antisocial personality disorder (ASPD), which focuses mainly on the behavioral aspects of psychopathy, such as aggression, impulsivity, and violations of others’ rights, but only minimally on personality characteristics like callousness, remorselessness, and narcissism. As a result, only about a third of those diagnosed with ASPD also meet the criteria for psychopathy, according to research using validated scales, which often leads to confusion over how and if the two conditions are related, Marsh noted.
At present, the closest DSM-V diagnosis to psychopathy is a youth diagnosis of conduct disorder with the addition of so-called “callous unemotional” (CU) traits, which manifest as a lack of guilt and remorse, a callous lack of empathy, a lack of concern about one’s performance on important activities, and a general lack of emotional expression, said Louisiana State University psychologist Paul Frick, PhD, a member of the DSM-V work group that developed those criteria. In the DSM-V, this diagnosis is known as “conduct disorder with a ‘limited prosocial emotion’ specifier.”
Given these varying factors, researchers are working to further clarify the nature of psychopathy by analyzing commonalities and differences between and among individuals in different settings, between assessment instruments, and across studies, and they are studying if and how children with the DSM-V specifier are at risk for psychopathy. Again, this newer line of thinking views psychopathy on a spectrum—as a set of traits that varies continuously throughout the population.
One effort to coordinate thinking in the field is Patrick’s “triarchic model,” which posits three separable trait constructs underlying psychopathic symptoms: “disinhibition,” which includes tendencies toward impulsiveness, irresponsibility, difficulty regulating one’s emotions and behavior, and mistrust of others; “meanness,” which involves deficits in empathy, contempt toward and inability to bond with others, and predatory exploitativeness; and “boldness,” which includes dominance, social assurance, emotional resilience, and adventurousness. Each of these traits has unique developmental features and neurobiological correlates. Patrick developed the Triarchic Psychopathy Measure to assess these trait constructs (
Development and Psychopathology
, Vol. 21, No. 3, 2009
opens in new window;
Journal of Personality
, Vol. 83, No. 6, 2015
opens in new window).
Because boldness, meanness, and disinhibition are separable, the triarchic model opens the door to understanding psychopathic symptoms in more flexible and nuanced ways and to a framework for integrating research that employs different theories and assessment instruments, Patrick said. In addition, the model suggests the possibility of identifying and studying subtypes of psychopathy involving different configurations of traits—for example people who display a “bold-disinhibited” style versus a “mean-disinhibited” one—and identifying neurobiological processes that relate to each subtype.
“If we can connect findings from different studies through reference to a common set of psychological dimensions, we can be more effective in identifying neurophysiological and behavioral factors that contribute to different expressions of psychopathy,” said Patrick. “And that synergy, that harmonization of efforts, can lead to new ways of thinking and to assessment methods that are more precise and less crude and redundant.”